Allurion Technologies (ALUR) announced its intention to initiate a clinical study on the combination of the Allurion Balloon with GLP-1 ...

Allurion Technologies, Inc. ("Allurion" or the "Company") , a company dedicated to ending obesity, today announced its intention to initiate a clinical study on the combination of the Allurion Balloon ...

Allurion Technologies Inc. is cleared by regulators in France to resume sales of its swallowable gastric balloon to treat ...

Allurion’s CEO confirmed to Medical Device Network that the company has changed advertising, patient follow-up, and physician ...

Allurion Technologies today announced the relaunch of its Allurion Balloon in France following regulatory clearance to resume ...

Allurion Technologies (ALUR) announced that it is relaunching the Allurion Balloon in France after ANSM, the French regulatory authority, ...

Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced that it is relaunching the Allurion Balloon in France after ANSM, the ...

The Allurion swallowable intragastric balloon offers a safe, effective and minimally invasive method of losing weight.

A lesser-known player, Allurion Technologies (ALUR), is carving a niche with its innovative solutions. The Massachusetts-based medical technology firm plans to test its gastric balloon-based Allurion ...